Royal Bank of Canada »

Allogene Therapeutics shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2023-12-31 $200k 63k 3.19
2023-09-30 $180k 56k 3.19
2023-06-30 $249k 49k 5.08
2022-12-31 $269k 42k 6.42
2022-09-30 $467k 43k 10.79
2021-06-30 $1.9M 93k 20.00
2021-03-31 $3.3M 95k 35.24
2020-12-31 $1.1M 43k 25.29
2020-09-30 $1.6M 41k 37.78
2020-06-30 $2.3M 54k 42.90
2020-03-31 $743k 38k 19.39
2019-12-31 $965k 37k 26.12
2019-09-30 $826k 30k 27.32
2019-03-31 $504k 17k 28.98
2018-12-31 $498k 18k 27.97